Home NDC 70518-4614-0 FARXIGA
Product NDC 70518-4614
Requested package NDC 70518-4614-0
11-digit product format 705184614
Labeler code 70518
Product ID 70518-4614_5bc230f9-4eb9-3de2-e063-6394a90aa3aa
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name DAPAGLIFLOZIN
Dosage form TABLET, FILM COATED
Route ORAL
Labeler REMEDYREPACK INC.
Application NDA202293
Marketing category NDA
Marketing start 2026-04-23
Substance DAPAGLIFLOZIN PROPANEDIOL
Active strength 5 mg/1
Pharmacologic classes Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N202293-001 FARXIGA DAPAGLIFLOZIN 5MG TABLET / ORAL AB RLD 2014-01-08 N202293-002 FARXIGA DAPAGLIFLOZIN 10MG TABLET / ORAL AB RLD, RS 2014-01-08
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 64 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 8 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N202293-001 FARXIGA 5MG TABLET / ORAL AB RLD 2014-01-08 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 FARXIGA 10MG TABLET / ORAL AB RLD, RS 2014-01-08 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N202293-001 FARXIGA 5MG TABLET / ORAL AB RLD 2014-01-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202293-002 FARXIGA 10MG TABLET / ORAL AB RLD, RS 2014-01-08 c2088c7a36db…2026-09-14 22:38:34 2026-08 N202293-001 FARXIGA 5MG TABLET / ORAL AB RLD 2014-01-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202293-002 FARXIGA 10MG TABLET / ORAL AB RLD, RS 2014-01-08 84e616aacf4f…2026-08-18 06:07:40 2026-07 N202293-001 FARXIGA 5MG TABLET / ORAL AB RLD 2014-01-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202293-002 FARXIGA 10MG TABLET / ORAL AB RLD, RS 2014-01-08 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N202293-001 FARXIGA 5MG TABLET / ORAL RLD 2014-01-08 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N202293-002 FARXIGA 10MG TABLET / ORAL RLD, RS 2014-01-08 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N202293-001 FARXIGA 5MG TABLET / ORAL AB RLD 2014-01-08 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N202293-002 FARXIGA 10MG TABLET / ORAL AB RLD, RS 2014-01-08 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N202293-001 FARXIGA 5MG TABLET / ORAL AB RLD 2014-01-08 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N202293-002 FARXIGA 10MG TABLET / ORAL AB RLD, RS 2014-01-08 5d02ea3f76ae…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 59 · 2,354 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N202293-001 6515117 2025-10-04 U-493 Drug substance, Drug product 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 6515117 2025-10-04 U-2139 Drug substance, Drug product 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 6515117*PED 2026-04-04 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8329648 2026-08-18 U-2213 2017-11-15 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8329648 2026-08-18 U-2139 2017-11-15 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8329648 2026-08-18 U-2212 2017-11-15 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8906851 2026-08-18 U-2139 2017-11-15 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8329648*PED 2027-02-18 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8906851*PED 2027-02-18 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8501698 2027-06-20 U-493 Drug product 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8501698*PED 2027-12-20 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8221786 2028-03-21 Drug product 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8361972 2028-03-21 U-2139 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8361972 2028-03-21 U-493 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8716251 2028-03-21 Drug product 2014-06-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 7851502 2028-08-19 Drug product 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8221786*PED 2028-09-21 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8361972*PED 2028-09-21 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8716251*PED 2028-09-21 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 7851502*PED 2029-02-19 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 7919598 2029-12-16 Drug substance 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8721615 2030-01-18 Drug product, Delist requested 2017-11-15 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8685934 2030-05-26 U-1522 2014-06-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 7919598*PED 2030-06-16 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8721615*PED 2030-07-18 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-001 8685934*PED 2030-11-26 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 6515117 2025-10-04 U-2139 Drug substance, Drug product 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 6515117 2025-10-04 U-493 Drug substance, Drug product 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 6515117*PED 2026-04-04 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 8329648 2026-08-18 U-2139 2017-11-15 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 8329648 2026-08-18 U-2212 2017-11-15 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 8329648 2026-08-18 U-2213 2017-11-15 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 8906851 2026-08-18 U-2139 2017-11-15 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 8329648*PED 2027-02-18 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 8906851*PED 2027-02-18 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 8501698 2027-06-20 U-493 Drug product 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 8501698*PED 2027-12-20 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 8221786 2028-03-21 Drug product 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 8361972 2028-03-21 U-2139 2014-02-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202293-002 8361972 2028-03-21 U-493 2014-02-05 d4dbc9d85df4…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 9 · 330 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base FARXIGA
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DAPAGLIFLOZIN PROPANEDIOL 5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 887K2391VH Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1486981 Internal RxNorm lookup 1488574 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70518-4614-0 FARXIGA 50 in 1 BOX TABLET, FILM COATED 50 1 70518-4614-1 FARXIGA 1 in 1 POUCH TABLET, FILM COATED 1 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 6 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 70518-4614-0 70518461400 50 POUCH in 1 BOX (70518-4614-0) / 1 TABLET, FILM COATED in 1 POUCH (70518-4614-1) 50 pouch 2026-04-23 No No Current